HAMAD MEDICAL CORPORATION
๐ถ๐ฆQatar
Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status
Phase 4
Recruiting
- Conditions
- TraumaBrain InjuriesBeta BlockersTroponinStress Reaction
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 771
- Registration Number
- NCT04508244
- Locations
- ๐ถ๐ฆ
Hamad General Hospital, Doha, Qatar
Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients
- Conditions
- COVID-19
- Interventions
- Other: Survey
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2020-07-16
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 25000
- Registration Number
- NCT04473118
- Locations
- ๐ถ๐ฆ
Hamad Medical Corporation, Doha, Qatar
Immune Profiling of COVID19-patients Admitted to ICU
- Conditions
- COVID-19
- Interventions
- Other: No intervention
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2020-07-16
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 300
- Registration Number
- NCT04473131
- Locations
- ๐ถ๐ฆ
Hamad Medical Corporation, Doha, Qatar
Inhaled Iloprost for Suspected COVID-19 Respiratory Failure
Phase 2
Completed
- Conditions
- ARDS, HumanHypoxemic Respiratory FailureCOVID-19
- Interventions
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT04445246
- Locations
- ๐ถ๐ฆ
Hamad Medical Corporation, Doha, Qatar
Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial
Phase 4
- Conditions
- Anticoagulation in COVID-19 ARDS
- Interventions
- Drug: Standard treatment
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2020-06-24
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT04445935
- Locations
- ๐ถ๐ฆ
Hamad Medical Corporation, Doha, Qatar
Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT04437693
Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2020-06-26
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT04430374
- Locations
- ๐ถ๐ฆ
Hamad Medical Corporation, Doha, Unlisted (UL), Qatar
Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar
Completed
- Conditions
- CoronavirusCOVIDPneumonia
- Interventions
- Drug: Darunavir/Cobicistat
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-08-16
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 400
- Registration Number
- NCT04425382
- Locations
- ๐ถ๐ฆ
Hamad Medical Corporation, Doha, Qatar
Flow Controlled Ventilation in ARDS Associated With COVID-19
Not Applicable
- Conditions
- ARDS Associated With COVID-19
- Interventions
- Device: Flow controlled ventilation (Evone-ventilator)
- First Posted Date
- 2020-05-22
- Last Posted Date
- 2020-06-25
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT04399317
- Locations
- ๐ถ๐ฆ
Hamad Medical Corporation, Doha, Qatar
Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19
Not Applicable
Completed
- Conditions
- Covid19
- Interventions
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 456
- Registration Number
- NCT04349592
- Locations
- ๐ถ๐ฆ
Hamad Medical Corporation, Doha, Qatar
ยฉ Copyright 2025. All Rights Reserved by MedPath